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Abstract We investigated the effect of pallidal deep
brain stimulation (GPi-DBS) in dystonia on cognition,
mood, and quality of life and also assessed if DYT1 gene
status influenced cognitive outcome following GPi-DBS.
Fourteen patients with primary generalized dystonia (PGD)
were assessed, measuring their estimated premorbid and
current IQ, memory for words and faces, and working
memory, language, executive function, and sustained
attention, one month before and one year or more after
surgery. Changes in mood and behaviour and quality of life
were also assessed. There was a significant improvement of
dystonia with GPi-DBS (69 % improvement in Burke-
Fahn-Marsden score, p \ 0.0001). Performance on five
cognitive tests either improved or declined at post-surgical
follow-up. Calculation of a reliable change index suggested
that deterioration in sustained attention on the PASAT was
the only reliable change (worse after surgery) in cognition
with GPi-DBS. DYT1 gene status did not influence cog-
nitive outcome following GPi-DBS. Depression, anxiety
and apathy were not significantly altered, and ratings of
health status on the EQ5D remained unchanged. In our
sample, GPi-DBS was only associated with an isolated
deficit on a test of sustained attention, confirming that GPi-
DBS in PGD is clinically effective and safe, without
adverse effects on the main domains of cognitive function.
The dissociation between GPi-DBS improving dystonia,
but not having a significant positive impact on the patients’
QoL, warrants further investigation.
Keywords Primary generalised dystonia  Deep
brain stimulation  Globus pallidus  Cognition 
Executive function
Introduction
Primary generalised dystonia (PGD) is a movement disor-
der associated with sustained muscle contractions and
abnormal postures. Unlike other disorders of the basal
ganglia such as Parkinson’s disease (PD), cognitive deficits
are not considered part of the clinical presentation or dis-
ease progression in PGD. Studies looking at cognitive
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Table 1 Studies investigating cognition in primary dystonia using detailed neuropsychological assessment
Author N Sample
characteristics
Neuropsychological battery Main findings
Taylor
et al. [1]
20 All idopathic dystonia
with no cognitive
impairment?
Wechsler memory
scale
Tower of Toronto
Buschke selective
reminding
Conditional
associative
Learning
Stroop
Wisconsin
Word fluency
Block counting
Compared to age matched healthy controls; no
differences found prior to medication.
However significant difference on explicit
memory and reduced speed of information
processing about 2–4 months after taking
15–74 mg of trihexyphenidyl daily
Jahanshahi
et al. [2]
10 10 Idiopathic
dystonia patients
3 generalized
dystonia
5 Cervical dystonia
2 Focal arm dystonia
National adult
reading test
Word fluency
Wisconsin card
sorting test
Stroop colour word
Naming test
Missing digit test
Self-ordered random
number sequence
test
Visual conditional
associative learning
Conditional associative
learning tests
Paced auditory serial
addition test
Dual ask performance
Repetition
random number generation
Only differences between the two groups was
on category word fluency and dual task
performance
Scott et al.
[3]
14 14 patients with focal,
segmental, or
generalized
dystonia
Cambridge
neuropsychological
test automated
battery
Wisconsin card
sorting test (set
shifting)
National adult
reading test
Raven’s standard
progressive
matrices
The symbol digit
modalities test
The Stroop test
Trail making test
Categorical and
phonemic verbal
fluency
Speed of Comprehension
from the speed and
capacity of language
processing test
Recognition memory test
Story recall subtest from
the adult memory and
information processing
battery
Wechsler adults
intelligence scale (digit
span)
Medical College of
Georgia Complex
Figures
Boston naming test
Judgement of line
orientation test
Only deficit on attentional set shifting on the
Cambridge neuropsychological test
automated batter. Significant difficulties
negotiating the extra-dimensional set-
shifting phase of the intra-extra dimensional
set shift task.
Balas et al.
[4]
28 28 DYT-1 gene
carriers with
childhood onset
generalized
dystonia:
20 symptomatic
DYT1 dystonia-
(SYM)
8 non- symptomatic
DYT1 dystonia- (N-
SYM)
Rey auditory verbal
learning test
Rey complex figure
Language phonemic
verbal fluency,
Semantic verbal
fluency
Trail-making A and B
Stroop test
Cambridge
neuropsychological
test automated
battery
Visual analog scale
Wechsler Adults
Intelligence Scale
III (digit span and
similarities)
Symbol search
Judgment of line
orientation
Purdue pegboard
Beck depression inventory
anxiety Spielberger state
and trait anxiety
questionnaire
No significant differences between the
N-SYM group and the control group on any
of the measures.
The only significant differences between the
SYM group and controls were that the SYM
group showed increased verbal memory
retroactive interference
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function in dystonia (summarized in Table 1) have con-
firmed that patients with primary dystonia do not exhibit
major deficits in intellectual ability, attention, memory, or
language [1–8]. However, specific deficits on tests of visuo-
spatial function relating to egocentric space [9], impaired
semantic fluency and dual task performance [2], greater
susceptibility to retroactive interference [4], deficits in set-
shifting [6], impairment in complex movement planning
and motor dexterity, visuospatial working memory and
tactile object recognition have been documented in primary
dystonia [7]. Some authors [3], but not others [4], have also
found a selective deficit in extra-dimensional set-shifting.
These differences across studies may be related to the het-
erogeneity across samples of the exact type and extent of
dystonia and/or to the presence/absence of neuropsychiatric
symptoms, particularly depression and anxiety, that are
common in dystonia and can be associated with cognitive
impairment. As previously suggested [2], some of these
deficits may be related to the patients’ attempts to control
their dystonia during cognitive testing. Supporting this,
Allam et al. [5] showed that improvement of blepharospasm
following botulinum toxin was associated with significant
improvement on a test of sustained attention.
Pallidal deep brain stimulation (GPi-DBS) is an estab-
lished and effective treatment for dystonia [10, 11]. The
safety of GPi-DBS for dystonia in relation to cognition has
been shown in neuropsychological studies [12, 13] and
clinical series following patients for up to three years
postoperatively [10, 14], which conclude that GPi-DBS
surgery does not affect post-operative cognition in primary
dystonia.
The aim of this study was twofold: (1) to investigate the
impact of bilateral GPi-DBS in PGD on cognitive function,
mood and quality of life, (2) to examine if DYT1 gene
status, which has been associated with better post-surgical
outcome after GPi-DBS in PGD [15], influences cognition
and mood following GPi-DBS.
Methods
Sample
Fourteen consecutive patients (10 = female) with PGD
undergoing bilateral GPi-DBS at the National Hospital for
Neurology and Neurosurgery were included. Demographic
and clinical details of the sample are presented in Table 2.
The mean age was 41.9 (range 18–64, SD = 18.5) and
mean duration of illness was 24.1 years (SD = 16.7).
Seven patients tested positive for the DYT1 torsion gene.
The Burke-Fahn-Marsden Scale [16] was used to assess the
severity of dystonia.
Table 1 continued
Author N Sample
characteristics
Neuropsychological battery Main findings
Allam et al.
[5]
9 9 patients with
primary carnial
dystonia
(blepharospasm)
Rey auditory verbal
learning test
Toulouse-Pieron test
Wechsler memory
scale-R-digit
subtest
Wechsler intelligence
scale-R-digit symbol
subtest
Stroop colour word
naming test
There were sustained attentional deficits prior
to botox injections.
Following botox injections, there were no
significant differences in sustained attention
compared with controls
Bugalho
et al. [6]
45 45 patients with
primary dystonia
(focal and
segmental):
15 blepharospasm
15 cervical dystonia
15 writer’s cramp
Wisconsin card
sorting test
Stroop test
Benton’s visual
retention test
Block assembly test from
Wechsler adults
intelligence scale
Yale brown obsessive
compulsive scale
Patients made more preservative errors on
Wisconsin Card sorting test and had a higher
mean obsessive compulsive score than
controls
Aleman
et al. [7]
20 20 patients with
primary carnial
dystonia
(blepharospasm)
Wechsler adults
intelligence scale
Five digits test-Stroop
Raven’s matrices
Luria’s task
Purdue pegboard
Oral making test
Digital recognition
Tactile denomination
Tapping test
Wechsler memory scale
Compared to controls, matched for severity of
depression and level of education, the
patients showed impaired; complex
movement planning, motor dexterity,
visuospatial working memory, and tactile
object recognition
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Neuropsychological assessment
Patients were assessed prior to surgery, and one year or
more post-operatively (mean duration of follow-up
14.4 ± 4.5 months).
The assessment battery included the following tests,
which were administered according to standard procedures
(for details of tests please see [2, 17]).
The Mini Mental State Examination (MMSE) [18] for
global cognitive functioning, the National Art Reading Test
(NART) [19] for premorbid IQ and the Wechsler Adult
Intelligence Test-Revised (WAIS-R) [20] for current verbal
IQ were used. The Auditory Verbal Learning Test (RAV-
LT) [21], the recognition memory for faces-short form
(RMF) [22] , and the Self-Ordered Pointing Test [23] were
respectively used to assess episodic memory for words,
memory for non-verbal material and working memory. The
phonemic, semantic and alternating versions of the Verbal
Fluency Test [24] and the Graded Naming Test [25] were
employed for language assessment. Tests of executive
function included the Modified Wisconsin Card Sorting
Test (MWCST) [26] for maintaining and shifting ‘set’, the
Stroop colour word naming task [27] to measure inhibition
of proponent/habitual responses, and the Trial Making Test
[28] for behavioural regulation and task switching. The
Paced Auditory Serial Addition Test (PASAT) [29] was
used to assess sustained attention.
The Beck Depression Inventory (BDI) [30], Beck Anxiety
Inventory (BAI) [31], and the Apathy Evaluation Scale
(AES) [32] were used to measure depression, anxiety and
apathy, respectively. Higher scores on these measures are
indicative of high depression, anxiety and apathy. The EQ5D
[33], which covers five quality of life (QoL) dimensions
(mobility, self-care, usual activities, pain/discomfort and
anxiety/depression), was used to measure QoL. The EQ5D
includes a visual analogue scale (VAS) used for rating
‘current health state’ with a range of 0(worst imaginable
health)–100(best imaginable health), and the five subscores
of the test can be combined to give a summary index value of
0–1, with lower scores representing poorer overall QoL.
Table 2 Demographic and clinical details of the dystonia patients
Gender Age
(years)
Disease
duration (years)
DYT 1
gene status
BFM score
pre-op (0–120)
BFM score
post-op (0–120)
Medication DBS parameters
1 F 18 9 ? 48 0 Trihexyphenidyl R: 4,5-, 3.9v, 60:ls, 130 Hz
L: 0,1-, 3.9v, 60:ls, 130 Hz
2 M 24 16 - 73 16 Clonazepam R: 4,5-, 3.9 v, 90:ls, 130 Hz
L: 0,1-, 3.8 v, 90:ls, 130 Hz
3 M 47 37 ? 52 24 Diazepam tetrabenazine R: 4-, 3.5v, 90:ls, 130 Hz
L: 0,1-, 3.3v, 60:ls, 130 Hz
4 F 23 12 - 53 33 None R: 5-, 4.0v, 60:ls, 130 Hz
L: 1-, 4.2v, 60:ls, 130 Hz
5 F 52 36 ? 29 9 None R: 4-, 3.0v, 60:ls, 130 Hz
L: 0-, 3.0v, 60:ls, 130 Hz
6 F 16 7 ? 20 4 L-Dopa trihexyphenidyl R: 4-, 2.9v, 60:ls, 130 Hz
L: 0-, 2.9v, 60:ls, 130 Hz
7 F 63 4 - 23 1 L-Dopa trihexyphenidyl R: 6-, 4.6v, 90:ls, 130 Hz
L: 2-, 4.6v, 90:ls, 130 Hz
8 F 54 43 - 24 12 None R: 4-, 3.7v, 60:ls, 130 Hz
L: 1-, 3.7v, 60:ls, 130 Hz
9 F 36 25 ? 21 1 Trihexyphenidyl R: 4-, 4.6v, 90:ls, 130 Hz
L: 0-, 4.2v, 90:ls, 130 Hz
10 M 62 43 - 28 15 Trihexyphenidyl
Baclofen
clonazepam
R: 6-, 3.7v, 90:ls, 130 Hz
L: 1-, 3.7v, 90:ls, 130 Hz
11 F 22 15 ? 51 11 Trihexyphenidyl
Baclofen
R: 4-, 3.6v, 60:ls, 130 Hz
L: 0-, 3.6v, 60:ls, 130 Hz
12 F 64 50 - 46 17 None R: 5,6-, 3.5v, 60:ls, 130 Hz
L: 1,2-, 3.5v, 60:ls, 130 Hz
13 M 62 7 - 64 38 None R: 4,5-, 3.5v, 60:ls, 130 Hz
L: 1,2-, 3.5v, 60:ls, 130 Hz
14 F 42 30 ? 27 7 None R: 5-, 3.5v, 60:ls, 130 Hz
L: 1, 3.5v, 60:ls, 130 Hz
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The study was approved by the Joint Research Com-
mittee of the National Hospital for Neurology and Neuro-
surgery and the Institute of Neurology, London, UK. All
patients gave written informed consent.
Results
Pre vs. post-operative change in dystonia
Mean BFM score was 39.9 (SD = 17.4) at baseline and
13.3 (SD = 11.6) after surgery. Dystonia was significantly
improved from before to after surgery[t(13) = 7.6,
p \ 0.0001]. The average improvement in dystonia was
68.7 % (±20.8).
Pre vs. post-operative change in cognitive function
At baseline, the mean predicted premorbid IQ from the
NART was 104.5 (SD = 13.2), which is in the average
range. With p \ 0.05, there was a significant change in
scores for five cognitive measures (see Table 3). Three
of these indicated poorer performance after surgery, and
two were suggestive of post-operative improvement.
The scaled score on digit span was lower[t(11) = 2.6,
p = 0.024], fewer items were recalled on RAVLT
(Trial 5)[t(13) = 2.6, p = 0.022], and there was a sig-
nificant increase in errors on PASAT[t(8) = -2.9,
p = 0.021]. In contrast, accuracy on the Stroop control
task improved [Z = 2.2, p = 0.027] and there were
fewer non-perseverative errors on the MWCST
[Z = 2.5, p = 0.013] after surgery. Inspection of the
individual data showed an average reduction of three
points on the WAIS-R digit span and two points on the
RAVLT (range ?2 to -7 on both tests), and an
increase of eight errors on the PASAT at follow-up
compared to baseline.
To determine if the significantly lower performance at
follow-up was statistically reliable, we calculated the reli-
able change index (RCI) for the related measures (Table 4).
RCI determines if change in a score from before to after an
intervention is statistically reliable by taking into account
the reliability of the measure [34]. The formula for calcu-
lating it is: RCI ¼ x2  x1=Sdiff baseline scoreð
follow- up score=the standard error of differenceÞ: The
Sdiff is calculated as
p
2ðSEÞ, with SE being the standard
error of measurement. The results are then grouped into
three categories showing the percentage of: reliable
improvement, reliable decline, or no change. The greatest
average change was observed for PASAT, and the RCI
echoes this, showing that at follow-up more participants
showed deterioration (45 %) than improvement (33 %) or
no change (22 %). Although only one patient made fewer
errors on the PASAT at follow-up compared to baseline
(one less error), the 33 % improvement calculated by the
RCI takes into account practice effects and is based on this
patient and two others; one with only one additional error
and the other with no additional errors. In contrast, RCI for
WAIS-R digit span showed no change in 58 %, improve-
ment in 25 % and deterioration in only 17 % post-surgery.
Similarly, the RCI result for RAVLT (Trial 5) indicated no
change in 50 % of participants, and although 21 % had
declined, 29 % had improved. Thus, the RCI results sug-
gest that only the change in PASAT was clinically
significant.
Pre-operative vs. post-operative change in mood
There were no significant changes in depression or anxiety
from baseline to follow-up [BAI: t(7) = -0.201,
p = 0.846; BDI: t(8) = -0.174, p = 0.866]. Based on the
scale’s cut-off points, on average the patients had mild
anxiety and no depression, both before and after surgery
(see Table 5). Similarly, there was no significant change in
apathy [AES: t(8) = -0.809, p = 0.442], or apathy sub-
scores (all p [ 0.05).
Pre-operative vs. post-operative change in quality
of life
There was no significant difference between assessments in
the EQ5D summary index [t(10) = 1.589, p = 0.141] or
VAS[t(10) = -0.101, p = 0.921]. However, the percentage
of patients experiencing problems was reduced post-sur-
gery compared to baseline in all EQ5D domains except
anxiety/depression, although these differences were not
significantly different (see Table 5). Correlation analyses
showed no statistical correlation between change in dys-
tonia and change in QoL from before to after surgery
(EQ5D summary index: r = -0.618, p = 0.057; EQ5D
vas, r = -0.115, p = 0.751).
DYT1 gene status and cognitive outcome with GPi-
DBS
A series of two-way ANOVAs with Group (DYT1 positive,
vs. negative) as the between-groups variable and time of
assessment (pre-surgery vs. post-surgery) as the within-
subject variable were completed. The results revealed only
a main effect of time for WAIS-R digit span
[F(1,10) = 6.66, p \ 0.05], RAVLT (Trial 5)
[F(1,12) = 6.25, p \ 0.05] and PASAT [F(1,7) = 8.84,
p \ 0.05] (see Table 3), but no significant interactions.
Therefore, the DYT1 gene status did not influence cogni-
tive outcome following GPi-DBS.
168 J Neurol (2014) 261:164–173
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Correlation of demographic and clinical features
with change in cognitive scores with GPi-DBS
We examined the association of clinical and demographic
features and change in cognitive measures using Pearson
correlation coefficients. Duration of illness correlated with
changes in trail making (version B) [r(14) = -0.58,
p \ 0.03] and trail making difference score (version B-A)
[r(14) = -0.60, p \ 0.02]. Age of onset correlated with
changes in trail making (version B) [r(14) = 0.55,
Table 3 Mean and standard
deviations (SD) of the pre-
surgical and post-surgical scores
for the dystonia patients on the
measures of cognitive function
*p \ 0.05
Measure Pre-surgery mean (SD) Post-surgery mean (SD) p value
Mini mental state examination (max = 30) 27.20 (2.90) 27.60 (2.32) 0.343
WAIS-R subtests
Digit span 10.42 (3.31) 7.92 (3.89) 0.024*
Similarities 12.33 (3.55) 10.83 (3.24) 0.124
Vocabulary 9.92 (3.55) 10.17 (3.46) 0.699
Verbal IQ (prorated) 103.73 (14.02) 93.36 (11.96) 0.094
RAVLT
Correct recall: Trial 1 (max 15) 5.79 (2.36) 5.71 (3.02) 0.932
Correct recall: Trial 5 (max 15) 12.64 (2.02) 11.00 (3.61) 0.022*
Recall intrusions 0.79 (0.97) 0.93 (1.33) 0.699
Recall repetitions 0.93 (1.21) 0.64 (1.15) 0.470
Recognition: total correct (max 15) 14.36 (1.27) 13.43 (2.31) 0.084
Recognition: false positives 0.86 (1.09) 1.36 (2.37) 0.390
Short recognition memory for faces
Total correct (max 25) 23.86 (1.41) 24.07 (2.20) 0.664
Subject-ordered pointing
4 items (mean errors) 0.10 (0.32) 0.40 (0.52) 0.081
8 items (mean errors) 1.60 (0.97) 1.10 (0.88) 0.244
12 items (mean errors) 2.10 (1.60) 2.20 (1.03) 0.853
Verbal fluency total words generated
Letter fluency 41.85 (18.49) 39.85 (15.89) 0.457
Category fluency 15.23 (5.49) 16.00 (6.05) 0.409
Category switching fluency 18.49 (5.13) 15.89 (4.40) 0.673
Graded naming test
Total correct (max 30) 19.29 (4.84) 20.07 (5.56) 0.085
Modified Wisconsin card sorting
Categories correctly sorted (max = 6) 5.73 (1.27) 5.73 (0.65) 1.00
Total errors 7.17 (5.22) 4.75 (3.77) 0.115
Perseverative errors 1.58 (1.62) 2.08 (3.03) 0.568
Non-perseverative errors 5.50 (4.36) 1.92 (1.98) 0.016*
Stroop
Control colour naming time(ms) 76.43 (21.54) 81.1 (25.12) 0.436
Control colour naming number of errors 1.38 (1.71) 0.38 (0.65) 0.02*
Stroop interference time(ms) 126.47 (44.61) 144.21 (50.59) 0.107
Stroop interference numbers of errors 2.61 (4.03)) 1.84 (4.91) 0.471
Difference score in completion time (ms) 50.04 (30.52) 63.14 (31.98) 0.168
Trails A and B
Trails A: completion time (ms) 57.24 (33.43) 61.61 (36.76) 0.409
Trails B: completion time (ms) 115.17 (78.26) 116.38 (66.6) 0.952
Difference Trail B-A (ms) 57.93 (65.87) 54.76 (48.25) 0.886
PASAT
Total errors (max 30) 6.55 (8.39) 14.56 (13.45) 0.02*
J Neurol (2014) 261:164–173 169
123
p \ 0.04]. The BMF pre-operative scores correlated with
changes in WAIS-R (verbal IQ) [r(14) = 0.61, p \ 0.02],
category fluency [r(13) = 0.615, p \ 0.03] and switching
[r(13) = 0.57, p \ 0.05].
The pulse width of the right contact correlated with
change in WAIS similarities [r(14) = 0.55, p \ 0.04]. The
amplitude of DBS on the right and left contact correlated
with changes in RAVLT (Trial 5) [r(14) = 0.68, p \ 0.01
and r(14) = 0.59, p \ 0.03, respectively]. There were no
other significant correlations, including between the stim-
ulation parameters and change in PASAT scores (all
p [ 0.05). Furthermore, we did not find a significant dif-
ference in PASAT change scores between patients with
high (90 ls) versus low (60 ls) pulse width (p [ 0.05).
Similarly with a median split on the DBS amplitudes,
patients with high versus low stimulation amplitudes did
not show any significant differences in PASAT change
scores (p [ 0.05).
Discussion
The results of this study confirmed the benefits of GPi-DBS
for PGD, showing a significant post-surgical improvement.
GPi-DBS did not affect IQ, memory, language and exec-
utive function. The only reliable change following surgery
was worse performance on PASAT. DYT1 gene status did
not influence post-surgical cognitive outcome. There were
no significant changes in depression, anxiety or apathy
after surgery. Despite fewer patients experiencing prob-
lems in four of the EQ5D domains after surgery, the dif-
ferences were not significant.
In line with previous literature, our results show no
change in most aspects of cognition following GPi-DBS
or subthalamic(STN)-DBS, and show variability in cog-
nitive outcomes, with findings of deterioration,
improvement, and no change [10, 14, 35]. In a case
series, Kleiner-Fisman et al. [35] reported a mild but
Table 4 Reliable change indices for the three cognitive measures showing post-operative decline in performance
Measure % Declined % No change % Improved 95 % RCI criterion
WAIS-R subtests
Digit span 16.67 % 58.33 % 25.00 % 2.10
RAVLT
Words recalled on Trial 5 21.43 % 50.00 % 28.57 % 1.30
PASAT
Errors 44.44 % 22.22 % 33.33 % 5.20
WAIS-R Wechsler adult intelligence scale, RAVLT Rey adult verbal learning test, PASAT Paced auditory serial addition test
Table 5 Self-ratings of
depression, anxiety, apathy,
effort, physical and mental
fatigue, and quality of life by
the patients with dystonia before
and after surgery
AES Apathy evaluation scale
Measure (range) Baseline Follow-up p value
Beck Depression Inventory (0–63) 7.22 (4.27) 7.44 (6.42) 0.866
Beck Anxiety Inventory (0–63) 11.89 (5.94) 12.38 (10.34) 0.846
AES-total apathy score (18–72) 26.89 (3.79) 27.78 (4.09) 0.442
AES: emotional subtest (2–8) 3.78 (1.20) 3.89 (1.45) 0.594
AES: cognitive subtest (8–32) 11.67 (2.29) 12.22 (2.39) 0.516
AES: behavioural subtest (5–20) 7.11 (1.36) 7.22 (1.39) 0.834
AES: other items (3–12) 4.33 (1.50) 4.44 (1.33) 0.842
Effort (0–10) 5.81 (3.54) 6 (2.76) 0.779
Physical fatigue (0–10) 5.00 (3.00) 4.09 (2.66) 0.138
Mental fatigue (0–10) 5.73 (3.64) 5.64 (3.44) 0.911
EQ5D domain
Mobility 92.31 % 75.00 % 0.167
Self care 30.77 % 25.00 % 1.00
Usual activities 61.54 % 50.00 % 0.167
Pain/discomfort 84.62 % 58.33 % 0.082
Anxiety/depression 30.77 % 50.00 % 0.167
EQ5D summary index 0.61 (0.22) 0.73 (0.15) 0.141
EQ5D health statue (VAS) 68.45 (20.47) 69.27 (17.66) 0.921
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non-significant decline in executive function, and sig-
nificantly worse verbal and visual memory after STN-
DBS. Similarly, Kiss [14] reported significant decline in
verbal fluency in one case and in verbal memory in
another but without any impact on the patient’s daily
life. In our study, RCI calculations showed that after
GPi-DBS only the deterioration in the PASAT was
clinically significant; whereas deterioration in digit span
and RAVLT(Trial 5), and improvement on MWCST and
stroop (control task) were not reliable.
Close inspection of the PASAT data showed that in all
but one participant, error scores had increased at follow-
up. PASAT requires participants to hold the last number
presented ‘on line’ in working memory, add it to the next
number, and provide their sum. Errors are often linked to
failure to respond, due to the inability to maintain atten-
tion/information in working memory, and/or to manipu-
late the information to generate a response. GPi-DBS
could have interfered with any of these processes,
resulting in poorer performance. The change in PASAT
scores did not have any significant associations with the
DBS parameters. The point of entry of the electrodes is
likely to be through the supplementary motor area (SMA,
BA 6). However, any ‘insult’ to frontal areas during
electrode entry is minimal, and it is likely that any effects
relate to chronic stimulation of the motor front-striatal
circuit. In the motor circuit there are separate projections
from the GPi to the motor cortex, SMA and the lateral
part of Brodmann area six, the lateral premotor cortex
[36]. Furthermore, the SMA and the lateral premotor
cortex are hyperactive in primary dystonia [37]. The SMA
and the lateral premotor cortex are among the areas
activated during performance of the PASAT [38], and
have been shown in animal experimentation to be
involved in response selection on the basis of internal
versus external cues [39], processes that are involved in
the PASAT in addition to working memory. It is thus
possible that the impaired performance on the PASAT
following GPi DBS in the present sample relates to the
effects of GPi stimulation on these medial and lateral
premotor areas. This proposal needs to be tested in future
studies.
Some studies have reported improvements in perfor-
mance on tests of cognitive function after GPi-DBS for
children with secondary dystonia [40] and adults with
dystonia [13]. Pillon et al. [13] reported mild but significant
improvement in performance on Raven progressive matri-
ces, WAIS-R (similarities), MWCST (non-perservative
errors) and free verbal recall, which were all maintained at
three years follow-up [10]. Halbig et al. [12] also found a
significant post-surgical improvement on the trail making
test (version A) after surgery. However, the pre-operative
assessment of cognition may have been affected by the
severity of dystonia and thus the post-operative improve-
ment may partly reflect the symptomatic improvement.
Where the interval between baseline and follow-up have
been short, practice effects may have influenced perfor-
mance. Also, the effects of anti-cholinergic medication
used for the treatment of dystonia on cognition and changes
of this medication following GPi-DBS needs to be con-
sidered. In this sample, there were no changes in medica-
tion between baseline and the post-surgical assessment. To
avoid the confounding effects of medication changes on the
time course of clinical improvement in dystonia after GPi-
DBS, no changes were made in medication for the first
12 months, so the 12 month post-op medications remained
the same as baseline. However after 30 months, four of the
six patients on Artane were able to reduce their dose by a
mean of 36–11 mg, and four others stopped or reduced
sulpiride, L-Dopa, baclofen, and/or diazepam by
24 months.
Patients positive for the DYT1 gene are shown to benefit
more from GPi-DBS in some [15] but not all studies [10,
11]. Our results show that DYT1 gene status did not
influence change in cognition with GPi-DBS. However,
correlational analyses suggest association between key
clinical variables and cognitive change following GPi-
DBS. A shorter duration of illness, older age of onset and
more severe dystonia prior to surgery were associated with
greater change in executive function and verbal IQ with
GPi-DBS. Higher amplitude and pulse width of GPi-DBS
were associated with greater change in concept formation
and verbal memory.
Despite significant improvement of dystonia, depression
and anxiety remained unchanged in our sample. The lack
of significant change in mood following GPi-DBS may
reflect the mild anxiety and absence of depression at
baseline. The majority of previous studies excluded cases
with major psychiatric illness from surgery [8]. While
some have found that mild-moderate depression improves
after GPi-DBS in dystonia [12, 14]; others have not [10,
11]. Generally, anxiety scores do not change with GPi-
DBS[8]. These suggest that depression and anxiety can
remain unchanged following successful GPi-DBS in dys-
tonia, as found in the current study. Suicide has been
documented in association with DBS in dystonia. Foncke
et al. [41] reported that two of their 16 participants treated
with GPi-DBS committed suicide. Suicide is preventable,
and regular monitoring of operated patients, including
direct enquiry about suicidal ideations is highly recom-
mended [8].
QoL is impaired in dystonia and a greater percent of
dystonia patients report problems on all EQ5D domains
compared to the general population [42]. After GPi-DBS, a
lower percent of patients in this study reported problems on
all EQ5D items except depression/anxiety. However, the
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summary index and VAS were not significantly altered by
surgery, and correlation analysis revealed no significance
between improvement in dystonia and change in QoL.
Although some studies report post-surgical improvement in
most QoL domains in dystonia [43], others suggest that
surgery primarily improves the physical domains and to a
lesser extent the emotional components of QoL [10]. Given
that surgery aims to improve QoL, a lack of positive impact
of improvement in dystonia on QoL is at first sight puz-
zling and of clinical concern. Why doesn’t the significant
improvement of dystonia translate into significant
improvement of QoL? One possibility is that generic
measures may not be sensitive in picking up changes
unique to PGD. The EQ5D measures mainly the physical
parameters of health, and the lack of improvement in QoL
may reflect the simplicity of the measure. Alternatively,
our current assessment techniques may not be targeting key
patient concerns, highlighting the need to also assess their
expectations. Also, while GPi-DBS produces relatively
rapid improvement of dystonia, psychosocial adjustment to
the functional improvements may require longer time. We
have some evidence for this from interviews with operated
patients [44], who expressed a need to adapt to their ‘new
and improved’ body. This was eloquently expressed by one
patient ‘‘Now, even though I have been given a new body, I
haven’t been given a new mind. It’s like plastic surgery,
you might change your nose but how you feel about
yourself is still the same’’. Such dissociation between the
physical change and psychological adjustment may be
quantifiable with longitudinal assessments of changes in
dystonia symptoms, mood and QoL, thus warranting fur-
ther investigation.
In conclusion, our results confirm that GPi-DBS is an
effective treatment for PGD without producing any major
adverse impact on cognition, other than isolated deterio-
ration of performance on a test of sustained attention.
Despite significant improvement of dystonia with GPi-
DBS, surgery did not significantly alter depression, anxi-
ety, apathy or QoL. This dissociation between GPi-DBS
improving dystonia but not having a significant positive
impact on the patients’ QoL warrants further investigation.
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